menu
    • menu

    Company profile for iOncologi

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    iOncologi is a biotechnology company focused on developing groundbreaking immunotherapy platforms to transform the treatment of solid tumor cancers. Their proprietary technologies aim to overcome tumor-induced immunosuppression and induce robust anti-tumor immune responses. The company's lead program, IONC101, is advancing to Phase I clinical trials as a monotherapy for refractory solid tumors. Additionally, iOncologi has acqu...
    iOncologi is a biotechnology company focused on developing groundbreaking immunotherapy platforms to transform the treatment of solid tumor cancers. Their proprietary technologies aim to overcome tumor-induced immunosuppression and induce robust anti-tumor immune responses. The company's lead program, IONC101, is advancing to Phase I clinical trials as a monotherapy for refractory solid tumors. Additionally, iOncologi has acquired TargImmune Therapeutics, enhancing its immunotherapy pipeline with receptor-targeted RNA delivery platforms.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    iOncologiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Gainesville, Florida
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ioncologi.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ioncologi Secures U.S. Patent; Studies Link COVID19 mRNA Vaccine
    Ioncologi Secures U.S. Patent; Studies Link COVID19 mRNA Vaccine

    19 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ioncologi-secures-foundational-us-patent-as-landmark-studies-link-covid19-mrna-vaccines-to-improved-survival-with-cancer-immunotherapy-302588396.html

    PR NEWSWIRE
    19 Oct 2025
    Share Share
    SandboxAQ, iOncologi Speed Up Glioblastoma Treatment
    SandboxAQ, iOncologi Speed Up Glioblastoma Treatment

    16 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sandboxaq-and-ioncologi-partner-to-accelerate-brain-cancer-treatment-with-ai-driven-drug-discovery-for-glioblastoma-302506387.html

    PR NEWSWIRE
    16 Jul 2025
    Share Share
    iOnctura appoints Chief Business Officer and Board Chair
    iOnctura appoints Chief Business Officer and Board Chair

    17 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ionctura-strengthens-leadership-with-appointments-of-chief-business-officer-and-board-chair-302402124.html

    PR NEWSWIRE
    17 Mar 2025
    Share Share
    iOncologi Acquires TargImmune Therapeutics
    iOncologi Acquires TargImmune Therapeutics

    17 Mar 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/ioncologi-acquires-targimmune-therapeutics/

    CONTRACTPHARMA
    17 Mar 2025
    Share Share
    iOncologi Appoints Dr. Mona and Mr. Paolo Fundar to Its Board
    iOncologi Appoints Dr. Mona and Mr. Paolo Fundar to Its Board

    17 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ioncologi-inc-announces-the-appointment-of-dr-mona-flores-and-mr-paolo-fundaro-to-its-board-of-directors-302402968.html

    PR NEWSWIRE
    17 Mar 2025
    Share Share
    Immunomic Therapeutics Announces Collaboration With iOncologi
    Immunomic Therapeutics Announces Collaboration With iOncologi

    23 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211123006210/en

    BUSINESSWIRE
    23 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search